Citius Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CTXR and other ETFs, options, and stocks.About CTXR
Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite.
CEOLeonard L. Mazur
CEOLeonard L. Mazur
Employees23
Employees23
HeadquartersCranford, New Jersey
HeadquartersCranford, New Jersey
Founded2007
Founded2007
Employees23
Employees23
CTXR Key Statistics
Market cap20.13M
Market cap20.13M
Price-Earnings ratio-0.22
Price-Earnings ratio-0.22
Dividend yield—
Dividend yield—
Average volume323.89K
Average volume323.89K
High today$1.11
High today$1.11
Low today$1.04
Low today$1.04
Open price$1.05
Open price$1.05
Volume180.99K
Volume180.99K
52 Week high$5.95
52 Week high$5.95
52 Week low$0.65
52 Week low$0.65
Stock Snapshot
As of today, Citius Pharmaceuticals(CTXR) shares are valued at $1.09. The company's market cap stands at 20.13M, with a P/E ratio of -0.22.
During the trading session on 2025-12-16, Citius Pharmaceuticals(CTXR) shares reached a daily high of $1.11 and a low of $1.04. At a current price of $1.09, the stock is +4.8% higher than the low and still -1.8% under the high.
Trading volume for Citius Pharmaceuticals(CTXR) stock has reached 180.99K, versus its average volume of 323.89K.
The stock's 52-week range extends from a low of $0.65 to a high of $5.95.
The stock's 52-week range extends from a low of $0.65 to a high of $5.95.
People also own
Based on the portfolios of people who own CTXR. This list is generated using Robinhood data, and it’s not a recommendation.